Kura Oncology, Inc. · 5 hours ago
Chief Compliance Officer
Maximize your interview chances
BiopharmaBiotechnology
Comp. & Benefits
Insider Connection @Kura Oncology, Inc.
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Establish and direct Kura Oncology’s compliance strategy by identifying and assessing compliance risks in partnership with the Executive Team and other members of senior management.
Provide insight and direction to the Executive Team regarding the overall development and implementation of the Compliance Program in their respective areas of responsibility to mitigate compliance risks.
Partner with senior leadership to maintain and further develop a strong culture of ethics and compliance, including personal accountability at all levels in the organization.
Report to the Board of Directors and Executive Team regarding the Compliance Program and material compliance related developments, highlighting key issues and recommending solutions.
Establish and direct periodic risk assessments and conduct related ongoing monitoring activities of the Compliance Program, as well as stay abreast of industry and enforcement developments, and recommend policy or procedure modifications when necessary.
Foster a culture of ethical behavior and integrity within the organization, encouraging employees to report concerns without fear of retaliation.
Develop training programs and learning platforms for all applicable disciplines and functional areas including but not limited to the company's business ethics and compliance policies and procedures.
Maintain current awareness of laws, regulations, emerging trends, proposed regulations/guidelines and industry best practices in the regulatory compliance arena.
Develop and lead the investigative capabilities of the organization in close collaboration with Legal, HR and other functions as appropriate. Investigate allegations of violations of policy or misconduct; conduct/coordinate investigations; communicate findings to the appropriate senior leadership and Board Committee, as necessary. Establish in collaboration with HR appropriate, fair, and equitable consequence management for confirmed violations.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
15+ years of relevant compliance and industry experience.
Minimum of 15 years of experience supporting publicly traded, commercial stage pharmaceutical companies to deliver at scale and within ethical and compliance boundaries.
Proven track record of identifying, raising, and solving challenging compliance and ethics issues.
Experience building best-in-class ethics and compliance programs.
Demonstrated strong track record of partnering with business management to provide guidance and implementation of effective compliance processes.
Demonstrated experience driving a culture of ethics and compliance that positively informs people’s actions and decisions.
Experience establishing ethics and compliance guidelines and standard operating procedures.
Preferred
Juris Doctor (J.D.) or equivalent international degree preferred, with active membership in a Bar Association or equivalent body.
Benefits
Career advancement/ development opportunities
Competitive comp package
Bonus
401K + Employer contributions
Generous stock options
ESPP Plan
20 days of PTO to start
18 Holidays (Including Summer & Winter Break)
Generous Benefits Package with a variety of plans available with a substantial employer match
Paid Paternity/Maternity Leave
In-Office Catered lunches
Home Office Setup
Lifestyle Spending Stipend
Commuter Stipend (Boston Office)
Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more!
Company
Kura Oncology, Inc.
Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer.
Funding
Current Stage
Public CompanyTotal Funding
$1.24BKey Investors
Bristol-Myers SquibbHercules CapitalEcoR1 Capital
2024-01-24Post Ipo Equity· $150M
2023-06-14Post Ipo Equity· $100M
2022-11-03Post Ipo Equity· $25M
Recent News
2024-12-11
2024-12-10
2024-12-09
Company data provided by crunchbase